deamidation

Creative Biolabs has established a platform to predict and assess a series of post-translational modifications of antibody therapeutics. Deamidation of asparagine residues is one of the most common post-translational modifications occurring in therapeutic proteins produced using recombinant DNA technology, resulting in the conversion of an asparagine residue to a mixture of isoaspartate and aspartate.